Avanos Selling General Administrative vs Total Revenue Analysis
AVNS Stock | USD 19.88 0.30 1.53% |
Avanos Medical financial indicator trend analysis is way more than just evaluating Avanos Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avanos Medical is a good investment. Please check the relationship between Avanos Medical Selling General Administrative and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.
Selling General Administrative vs Total Revenue
Selling General Administrative vs Total Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avanos Medical Selling General Administrative account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Avanos Medical's Selling General Administrative and Total Revenue is 0.51. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Avanos Medical, assuming nothing else is changed. The correlation between historical values of Avanos Medical's Selling General Administrative and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Avanos Medical are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Selling General Administrative i.e., Avanos Medical's Selling General Administrative and Total Revenue go up and down completely randomly.
Correlation Coefficient | 0.51 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Selling General Administrative
Total Revenue
Total revenue comprises all receipts Avanos Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most indicators from Avanos Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avanos Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.At this time, Avanos Medical's Discontinued Operations is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 286.2 M in 2024.
2021 | 2022 | 2024 (projected) | Interest Expense | 3.3M | 10M | 16.1M | Depreciation And Amortization | 38.5M | 48.9M | 43.6M |
Avanos Medical fundamental ratios Correlations
Click cells to compare fundamentals
Avanos Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avanos Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 1.7B | 1.6B | 1.8B | 1.7B | 1.5B | |
Other Current Liab | 114.8M | 83.2M | 68.1M | 98.9M | 156.9M | 88.7M | |
Total Current Liabilities | 212.5M | 166.3M | 139.2M | 185.8M | 234.6M | 200.5M | |
Total Stockholder Equity | 1.3B | 1.3B | 1.3B | 1.3B | 1.2B | 1.4B | |
Other Liab | 11.2M | 16.7M | 18.7M | 48.9M | 56.2M | 30.6M | |
Net Tangible Assets | 280M | 296.3M | 321.1M | 220.8M | 253.9M | 181.9M | |
Retained Earnings | (288.3M) | (315.5M) | (310.3M) | (253.1M) | (314.9M) | (330.6M) | |
Accounts Payable | 83M | 67.6M | 56.4M | 67.9M | 56.3M | 86.0M | |
Cash | 205.3M | 111.5M | 118.5M | 127.7M | 87.7M | 147.2M | |
Other Assets | 27.4M | 71M | 26.5M | 22.2M | 25.5M | 24.3M | |
Long Term Debt | 248.1M | 180M | 130M | 226.3M | 159.4M | 256.1M | |
Net Receivables | 150.5M | 163.8M | 167.9M | 131.2M | 142.8M | 183.0M | |
Good Will | 800.9M | 802.5M | 801.6M | 819.4M | 796.1M | 728.2M | |
Retained Earnings Total Equity | (288.3M) | (315.5M) | (310.3M) | (253.1M) | (227.8M) | (239.2M) | |
Common Stock Shares Outstanding | 47.6M | 47.8M | 48.6M | 47.3M | 46.6M | 51.7M | |
Inventory | 145.9M | 168.9M | 150.3M | 190.3M | 163.2M | 152.4M | |
Other Current Assets | 57.2M | 23.5M | 18.9M | 13.9M | 93.3M | 98.0M | |
Other Stockholder Equity | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.7B | |
Total Liab | 534.4M | 416.3M | 330.7M | 495.7M | 456.1M | 466.7M | |
Total Current Assets | 538.5M | 467.2M | 418.6M | 499.8M | 487M | 627.7M | |
Accumulated Other Comprehensive Income | (32M) | (28.1M) | (33.8M) | (35.8M) | (27M) | (28.4M) | |
Treasury Stock | (5.3M) | (8.9M) | (9.8M) | (21.3M) | (19.2M) | (18.2M) | |
Intangible Assets | 168.2M | 184.3M | 157.7M | 251M | 239.5M | 166.7M | |
Property Plant Equipment | 184.5M | 175.3M | 168.1M | 163.9M | 147.5M | 161.6M | |
Short Long Term Debt Total | 325.4M | 248.8M | 187.5M | 280M | 209.1M | 264.0M | |
Property Plant And Equipment Net | 248.5M | 223.6M | 206.7M | 194.5M | 144M | 183.3M | |
Net Debt | 120.1M | 137.3M | 69M | 152.3M | 121.4M | 148.1M | |
Non Current Assets Total | 1.3B | 1.2B | 1.2B | 1.3B | 1.2B | 1.1B | |
Non Currrent Assets Other | 11.3M | 11.8M | 16.5M | 17.6M | 19.3M | 12.0M | |
Cash And Short Term Investments | 205.3M | 111.5M | 118.5M | 127.7M | 87.7M | 159.4M | |
Liabilities And Stockholders Equity | 1.8B | 1.7B | 1.6B | 1.8B | 1.7B | 1.6B | |
Non Current Liabilities Total | 321.9M | 250M | 191.5M | 309.9M | 221.5M | 288.4M | |
Property Plant And Equipment Gross | 248.5M | 223.6M | 206.7M | 194.5M | 266.9M | 191.5M | |
Long Term Debt Total | 248.1M | 180M | 130M | 226.3M | 203.7M | 273.0M | |
Capital Surpluse | 1.6B | 1.6B | 1.6B | 1.6B | 1.9B | 1.7B | |
Non Current Liabilities Other | 73.8M | 64.3M | 51.9M | 18.7M | 4.1M | 3.9M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avanos Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avanos Medical's short interest history, or implied volatility extrapolated from Avanos Medical options trading.
Pair Trading with Avanos Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avanos Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avanos Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Avanos Stock
0.54 | DYNT | Dynatronics Fiscal Year End 26th of September 2024 | PairCorr |
The ability to find closely correlated positions to Avanos Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avanos Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avanos Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avanos Medical to buy it.
The correlation of Avanos Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avanos Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avanos Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avanos Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Avanos Stock analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Avanos Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share (0.03) | Revenue Per Share 14.626 | Quarterly Revenue Growth 0.043 | Return On Assets 0.0218 |
The market value of Avanos Medical is measured differently than its book value, which is the value of Avanos that is recorded on the company's balance sheet. Investors also form their own opinion of Avanos Medical's value that differs from its market value or its book value, called intrinsic value, which is Avanos Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avanos Medical's market value can be influenced by many factors that don't directly affect Avanos Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.